Ralph A. Tripp

Chief Science Officer

Dr.Ralph Tripp’s main focus is on developing translational disease intervention strategies for emerging respiratory viruses. He has been a professor and Georgia Research Alliance Chair in vaccine and therapeutic development at the University of Georgia for 24 years. Dr. Tripp is a viral immunologist, having experience in molecular biology and biochemistry with a Ph.D. from Oregon State University. TrippBio was named after Dr. Tripp and his amazing work in the field of disease intervention.